XML 20 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
REVENUE    
Sales $ 933,715 $ 105,034
Cost of goods sold 766,779 77,979
Gross profit 166,936 27,055
OPERATING EXPENSES    
General and administrative expenses, includes $1,516,805 and $3,927,551 in stock-based compensation, respectively 15,985,552 22,084,389
Research and development, includes $591,518 and $713,130 in stock-based compensation, respectively 7,268,084 5,042,617
Sales and marketing, includes $1,023,045, and $0 in stock-based compensation, respectively 1,849,460 334,977
Impairment on notes receivable 543,938 14,500,000
Total operating expenses 25,647,034 41,961,983
NET LOSS FROM OPERATIONS (25,480,098) (41,934,928)
OTHER EXPENSE    
Interest expense (753,038) (93,209)
Interest income 57,348 3,101
Other income 58,960
Loss on extinguishment of debt (2,500,970)
Amortization of debt discount (1,533,048) (1,845,358)
Total other expense (2,169,778) (4,436,436)
Net loss before income taxes (27,649,876) (46,371,364)
Income tax provision
NET LOSS (27,649,876) (46,371,364)
Implied Dividends (37,667) (102,267)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (27,612,199) $ (46,269,097)
Net loss per share - basic and diluted (in Dollars per share) $ (14.89) $ (121.18)
Weighted average number of shares outstanding during the year - basic and diluted (in Shares) 1,854,724 381,811